SCLX
NASDAQScilex Holding Company
News25/Ratings6
News · 26 weeks87+100%
2025-10-262026-04-19
Mix1890d
- SEC Filings10(56%)
- Other4(22%)
- Insider2(11%)
- Market1(6%)
- Dividends1(6%)
Latest news
25 items- PRScilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026PALO ALTO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its Board of Directors (the "Scilex Board") approved a dividend of Dream Bowl I Meme Coin Tokens held by the Company (the "Dream Bowl Tokens") to its stockholders and certain other eligible equityholders of Scilex (collectively, the "Participating Holders"). The record date for the Dividend is April 30, 2026 (the "Record Date").
- INSIDERSEC Form 4 filed by Ma Stephen Hoi4 - Scilex Holding Co (0001820190) (Issuer)
- INSIDERSEC Form 4 filed by Ji Henry4 - Scilex Holding Co (0001820190) (Issuer)
- SECSEC Form S-3 filed by Scilex Holding CompanyS-3 - Scilex Holding Co (0001820190) (Filer)
- SECSEC Form 10-K filed by Scilex Holding Company10-K - Scilex Holding Co (0001820190) (Filer)
- SECSEC Form NT 10-K filed by Scilex Holding CompanyNT 10-K - Scilex Holding Co (0001820190) (Filer)
- SECScilex Holding Company filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Scilex Holding Co (0001820190) (Filer)
- PRScilex Holding Company Files Federal Securities Fraud Lawsuit Seeking Recovery of Approximately Ninety-Six (96) Million Misappropriated Collateral Shares of Datavault AI, Inc. from Marc Wade, The St. James Bank & Trust Company Ltd., Omega & Corinth Group Ltd., The Bank of New York Mellon Corporation, and Related PartiesPALO ALTO, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that it has filed a complaint (the "Complaint") in the United States District Court for the Central District of California against Marc Wade, The St. James Bank & Trust Company Ltd. ("St. James Bank"), Omega & Corinth Group Ltd., and related parties (collectively, the "Wade Defendants"), alleging a scheme involving the unauthorized tr
- SECScilex Holding Company filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Scilex Holding Co (0001820190) (Filer)
- SECSEC Form 424B3 filed by Scilex Holding Company424B3 - Scilex Holding Co (0001820190) (Filer)
- SECSEC Form 424B3 filed by Scilex Holding Company424B3 - Scilex Holding Co (0001820190) (Filer)
- SECSEC Form 424B3 filed by Scilex Holding Company424B3 - Scilex Holding Co (0001820190) (Filer)
- SECScilex Holding Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Scilex Holding Co (0001820190) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Scilex Holding CompanySCHEDULE 13G/A - Scilex Holding Co (0001820190) (Subject)
- NEWSDatavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 2026Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue.Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024.The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million.PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 5, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world ass
- SECScilex Holding Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders8-K - Scilex Holding Co (0001820190) (Filer)
- SECScilex Holding Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Scilex Holding Co (0001820190) (Filer)
- PRScilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis MarketsPALO ALTO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that it has made a $20 million strategic investment in Quantum Scan Holdings, Inc. ("Quantum Scan"), a breakthrough medical technology company, targeting trillion-dollar market of preventive diagnosis and prognosis of human diseases and illness. The investment is intended to support Quantum Scan's ongoing efforts to identify, develop,
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Scilex Holding CompanySCHEDULE 13D/A - Scilex Holding Co (0001820190) (Filed by)
- INSIDERLarge owner Scilex Holding Co sold $13,215,896 worth of shares (15,965,541 units at $0.83), decreasing direct ownership by 7% to 213,766,229 units (SEC Form 4)4 - Scilex Holding Co (0001820190) (Reporting)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Scilex Holding CompanySCHEDULE 13D/A - Scilex Holding Co (0001820190) (Filed by)
- INSIDERLarge owner Scilex Holding Co sold $18,176,455 worth of shares (14,713,490 units at $1.24), decreasing direct ownership by 6% to 229,731,770 units (SEC Form 4)4 - Scilex Holding Co (0001820190) (Reporting)
- SECSEC Form RW filed by Scilex Holding CompanyRW - Scilex Holding Co (0001820190) (Filer)
- PRScilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property CounselPALO ALTO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, announced that it has appointed Kasowitz LLP and its founding partner Marc Kasowitz as the Company's litigation and intellectual property counsel. Kasowitz LLP will advise Scilex on complex commercial litigation, patent litigation, intellectual property enforcement and defense, licensing matters, and strategic intellectual property governance as the C
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Scilex Holding CompanySCHEDULE 13D/A - Scilex Holding Co (0001820190) (Filed by)